{"id":"https://genegraph.clinicalgenome.org/r/15def9c6-8b46-4187-a69e-9177aae90f72v1.0","type":"EvidenceStrengthAssertion","dc:description":"C3 was first reported in relation to autosomal dominant atypical hemolytic uremic syndrome (aHUS) in 2008 (FrÃ©meaux-Bacchi et al., PMID: 18796626). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in phenotypic variability. Therefore, the following diseases have been split into separate entities, aHUS (OMIM: 612925) and C3 glomerulopathy (C3G) (OMIM: 613779). The split curation for semidominant C3G will be conducted separately. Thirteen variants (missense) that have been reported in thirteen probands in three publications (PMIDs: 18796626, 25608561, 26826462) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be gain of function. This gene-disease relationship is also supported by biochemical function in the complement mediated immune response, protein interaction with CFH and CFI, and a mouse model phenocopying disease in humans (PMIDs: 9291131, 21285368, 30714990). In summary, there is definitive evidence supporting the relationship between C3 and autosomal dominant aHUS. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Complement Mediated Kidney Diseases GCEP on the meeting date August 3, 2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/15def9c6-8b46-4187-a69e-9177aae90f72","GCISnapshot":"https://genegraph.clinicalgenome.org/r/78a4d83e-8fb0-4b47-9dfc-5dfe618e1aa3","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/78a4d83e-8fb0-4b47-9dfc-5dfe618e1aa3_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10069","date":"2023-09-29T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/78a4d83e-8fb0-4b47-9dfc-5dfe618e1aa3_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10069","date":"2023-09-29T15:31:15.335Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78a4d83e-8fb0-4b47-9dfc-5dfe618e1aa3_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78a4d83e-8fb0-4b47-9dfc-5dfe618e1aa3_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67a8b9fa-d985-40b7-a104-ef514e02dce4","type":"EvidenceLine","dc:description":"This model was upgraded due to phenotypic specificity caused by a variant observed in human patients.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94ed06f8-6def-4750-82a5-77d0cef39d0d","type":"Finding","dc:description":"When transferred to mice, an aHUS-associated gain-of-function change (D1115N) to the complement-activation protein C3 results in aHUS. Homozygous C3 p.D1115N (C3KI) mice developed spontaneous chronic thrombotic microangiopathy together with hematuria, thrombocytopenia, elevated creatinine, and evidence of hemolysis. Mice with active disease had reduced plasma C3 with C3 fragment and C9 deposition within the kidney. This data provide in vivo modeling evidence that gain-of-function changes in complement C3 drive aHUS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30714990","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/78a4d83e-8fb0-4b47-9dfc-5dfe618e1aa3_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bf96ed3-f9d4-45e0-88fc-be368b54d8b9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30c63fc4-0514-4850-a5c3-088ce37ea304","type":"Finding","dc:description":"This explains how some variants in FH reduce control of C3b on non-activator surfaces, leading to aHUS. Dysregulation of the alternative C3 convertase leads ultimately to complement-induced endothelial damage and ultimately thrombotic microangiopathy.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21285368","rdfs:label":"C3 Complement Regulation","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/58b000f9-356f-4141-a445-67f525da2330","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fcf6414-b6d9-407b-a981-8707b8da3142","type":"Finding","dc:description":"Using a microtitre plate assay, direct binding between complement factors I and H was demonstrated, and ligand blotting indicated that factor H interacts with the heavy chain of factor I. Similarly, direct C3(NH3)-factor I and C3(NH3)-factor H binding was characterized [where C3(NH3) is a form of C3 that is cleaved by factor I in the presence of factor H]. Both factor H and factor I interacted with both chains of C3(NH3) in ligand blotting.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9291131","rdfs:label":"CFI Binding","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/80c9474e-f5e6-464a-9f4b-3d7795e7cbb0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cfb790b-076e-4159-a85f-6178133176f9","type":"Finding","dc:description":"Using a microtitre plate assay, direct binding between complement factors I and H was demonstrated, and ligand blotting indicated that factor H interacts with the heavy chain of factor I. Similarly, direct C3(NH3)-factor I and C3(NH3)-factor H binding was characterized [where C3(NH3) is a form of C3 that is cleaved by factor I in the presence of factor H]. Both factor H and factor I interacted with both chains of C3(NH3) in ligand blotting.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9291131","rdfs:label":"CFH binding","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5},{"id":"https://genegraph.clinicalgenome.org/r/78a4d83e-8fb0-4b47-9dfc-5dfe618e1aa3_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29e6817e-e362-4a02-92b8-bfb6ee034439","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29e6817e-e362-4a02-92b8-bfb6ee034439_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased FH binding affinity, Decreased MCP binding affinity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/29e6817e-e362-4a02-92b8-bfb6ee034439_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25608561","allele":{"id":"https://genegraph.clinicalgenome.org/r/deccabf7-4cfc-4dc6-a25f-26134bfc566f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3124C>G (p.Arg1042Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403628516"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0560a516-e78c-44b7-9d50-104c91d35c1e","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0560a516-e78c-44b7-9d50-104c91d35c1e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased FH binding affinity, 23%WT FH cofactor activity, Decreased MCP binding affinity, 0%WT MCP cofactor activity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0560a516-e78c-44b7-9d50-104c91d35c1e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25608561","allele":{"id":"https://genegraph.clinicalgenome.org/r/6444d634-2507-4caa-b4b8-9484fc7f5604","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3284T>G (p.Ile1095Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403626272"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/32b1c74e-e966-43bc-b4e6-10ec27981446","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32b1c74e-e966-43bc-b4e6-10ec27981446_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased FH binding affinity, 14%WT FH cofactor activity, Decreased MCP binding affinity, 51%WT MCP cofactor activity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/32b1c74e-e966-43bc-b4e6-10ec27981446_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25608561","allele":{"id":"https://genegraph.clinicalgenome.org/r/43098b87-56b9-4005-a9b7-6b04d4882145","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3280G>T (p.Ala1094Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403626318"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/22742dcb-590c-4e03-8105-871798eaf56a","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22742dcb-590c-4e03-8105-871798eaf56a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased FH binding affinity, 67%WT FH Cofactor Activity, 67%WT MCP Cofactor Activity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/22742dcb-590c-4e03-8105-871798eaf56a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25608561","allele":{"id":"https://genegraph.clinicalgenome.org/r/da45023e-12b6-4ed1-8fae-888f246afde7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.553C>G (p.Gln185Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403643470"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a3bddfb1-c21e-42de-842c-ac9a57dab4cb","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3bddfb1-c21e-42de-842c-ac9a57dab4cb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"17% binding to MCP of wild-type, leading to resistance to cleavage by factor I.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a3bddfb1-c21e-42de-842c-ac9a57dab4cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18796626","allele":{"id":"https://genegraph.clinicalgenome.org/r/a1a36858-4cb9-4957-887f-fc0858b62a67","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3343G>A (p.Asp1115Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257695"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/adfb30d3-91e2-4515-a6a2-1b3fd3e6d6ee","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/adfb30d3-91e2-4515-a6a2-1b3fd3e6d6ee_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"22% binding to MCP of wild-type, leading to resistance to cleavage by factor I.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/adfb30d3-91e2-4515-a6a2-1b3fd3e6d6ee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18796626","allele":{"id":"https://genegraph.clinicalgenome.org/r/43b4c3b7-3ad4-4309-9ee1-69d7b354726f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.1775G>A (p.Arg592Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257691"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7b6c953f-f9cf-49fa-ac07-abe5bf1d33f6","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b6c953f-f9cf-49fa-ac07-abe5bf1d33f6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased FH binding affinity, Decreased MCP binding affinity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7b6c953f-f9cf-49fa-ac07-abe5bf1d33f6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26826462","allele":{"id":"https://genegraph.clinicalgenome.org/r/6121809b-fd97-4fc6-914d-5f16ee537d4f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3470T>C (p.Ile1157Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403624011"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ce43c1d4-dee5-4497-9a35-db8dc0ca56dc","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce43c1d4-dee5-4497-9a35-db8dc0ca56dc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"18% binding to MCP of wild-type, leading to resistance to cleavage by factor I.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ce43c1d4-dee5-4497-9a35-db8dc0ca56dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18796626","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4e5c07a-6aa7-4aa5-9216-19bd69457d53","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3281C>T (p.Ala1094Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257693"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/73d952f3-bf52-4823-ad85-c370b300b319","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73d952f3-bf52-4823-ad85-c370b300b319_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased FH binding affinity, Decreased MCP binding affinity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/73d952f3-bf52-4823-ad85-c370b300b319_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25608561","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1e654d2-81f7-4635-885c-aa863e7bd7cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.485C>A (p.Thr162Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403644902"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4cfc8b7b-01a8-4e24-93e6-41775fc273bd","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4cfc8b7b-01a8-4e24-93e6-41775fc273bd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"69% binding to MCP of wild-type, leading to resistance to cleavage by factor I.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4cfc8b7b-01a8-4e24-93e6-41775fc273bd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18796626","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3faa6d3-ba0f-430f-8c64-36b927cce037","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3481C>A (p.Gln1161Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403623929"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a835291a-3d2c-404d-96be-2c2aebd341c9","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a835291a-3d2c-404d-96be-2c2aebd341c9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased MCP binding affinity, 53% MCP Cofactor Activity, Increased FB binding","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a835291a-3d2c-404d-96be-2c2aebd341c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25608561","allele":{"id":"https://genegraph.clinicalgenome.org/r/59050062-b9ad-4b78-9ecb-9f43612a9ff1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.481C>T (p.Arg161Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA403644909"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/079f5190-3734-4563-a66b-ccab368fdb44","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/079f5190-3734-4563-a66b-ccab368fdb44_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"30% binding to MCP of wild-type, leading to resistance to cleavage by factor I.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/079f5190-3734-4563-a66b-ccab368fdb44_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18796626","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c854b20-8523-4f92-8a37-8f6b6ef374ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.1774C>T (p.Arg592Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9129335"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1654a1e0-783b-4de2-aab5-74a283b67d11","type":"EvidenceLine","dc:description":"This variant was upgraded for functional evidence supporting the gain of function mechanism of disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1654a1e0-783b-4de2-aab5-74a283b67d11_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased FH binding affinity, Decreased MCP binding affinity, Decreased CR1 binding affinity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1654a1e0-783b-4de2-aab5-74a283b67d11_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25608561","allele":{"id":"https://genegraph.clinicalgenome.org/r/ef29822f-6c86-42d2-91f4-92a581523584","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000064.4(C3):c.3187A>C (p.Ser1063Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9128825"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":7005,"specifiedBy":"GeneValidityCriteria9","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/pZKjqain5Ik","type":"GeneValidityProposition","disease":"obo:MONDO_0013043","gene":"hgnc:1318","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_78a4d83e-8fb0-4b47-9dfc-5dfe618e1aa3-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}